ArticleBlood neoplasia2025

Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML.

Mengdan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.